Our mission is dedicated to improving the application and success of hematopoietic cell transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.
Become a Member
ASTCT Talks features industry leaders coming together to tackle important subjects in the growing field of transplantation and cellular therapy. You can listen to ASTCT Talks on the following platforms: Spotify, Google Podcasts and Apple Podcasts.
Listen Here
Now Available! Access the latest issue of Transplantation and Cellular Therapy
Read the Journal
Access the latest news, session previews, and speaker spotlights from the 2025 Tandem Meetings.
Read More
View More
Check Out the Guideline
We are excited to announce an upcoming virtual roundtable on Wednesday, April 23, at 2 p.m. CDT that will delve into insights and key takeaways from ASH Annual Meeting and 2025 Tandem Meetings. This will be a great opportunity to explore and discuss latest advancements impacting BMT and cellular therapy and connect with your peers on these recent developments in our field.
During the webinar, Drs. White and Nezalova-Henriksen will present two articles related to: (a) Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic HSCT for older patients with AML or MDS and (b) Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients.
Join us for an expert-led session exploring the rising concern of measles outbreaks and their unique risks for patients undergoing Hematopoietic Cell Transplantation (HCT) and CAR T-cell therapies.
More Meetings
Browse all Education